• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有药物依从性的一室药代动力学模型的统计分析

Statistical analysis of one-compartment pharmacokinetic models with drug adherence.

作者信息

Yan Dingding, Wu Xiaotian, Tang Sanyi

机构信息

School of Mathematics and Statistics, Shaanxi Normal University, Xi'an, People's Republic of China.

College of Arts and Sciences, Shanghai Maritime University, Shanghai, People's Republic of China.

出版信息

J Pharmacokinet Pharmacodyn. 2022 Apr;49(2):209-225. doi: 10.1007/s10928-021-09794-5. Epub 2021 Oct 27.

DOI:10.1007/s10928-021-09794-5
PMID:34708336
Abstract

Pharmacokinetics is a scientific branch of pharmacology that describes the time course of drug concentration within a living organism and helps the scientific decision-making of potential drug candidates. However, the classical pharmacokinetic models with the eliminations of zero-order, first-order and saturated Michaelis-Menten processes, assume that patients perfectly follow drug regimens during drug treatment, and the significant factor of patients' drug adherence is not taken into account. In this study, therefore, considering the random change of dosage at the fixed dosing time interval, we reformulate the classical deterministic one-compartment pharmacokinetic models to the framework of stochastic, and analyze their qualitative properties including the expectation and variance of the drug concentration, existence of limit drug distribution, and the stochastic properties such as transience and recurrence. In addition, we carry out sensitivity analysis of drug adherence-related parameters to the key values like expectation and variance, especially for the impact on the lowest and highest steady state drug concentrations (i.e. the therapeutic window). Our findings can provide an important theoretical guidance for the variability of drug concentration and help the optimal design of medication regimens. Moreover, The developed models in this paper can support for the potential study of the impact of drug adherence on long-term treatment for chronic diseases like HIV, by integrating disease models and the stochastic PK models.

摘要

药代动力学是药理学的一个科学分支,它描述了药物在生物体内的浓度随时间变化的过程,并有助于对潜在候选药物进行科学决策。然而,经典的药代动力学模型,包括零级、一级消除以及饱和米氏过程,假定患者在药物治疗期间能完美遵循给药方案,而未考虑患者药物依从性这一重要因素。因此,在本研究中,考虑到在固定给药时间间隔内剂量的随机变化,我们将经典的确定性单室药代动力学模型重新构建为随机框架,并分析其定性性质,包括药物浓度的期望和方差、极限药物分布的存在性以及诸如暂态和常返性等随机性质。此外,我们对与药物依从性相关的参数进行敏感性分析,以研究其对期望和方差等关键值的影响,特别是对最低和最高稳态药物浓度(即治疗窗)的影响。我们的研究结果可为药物浓度的变异性提供重要的理论指导,并有助于优化给药方案的设计。此外,本文所建立的模型通过整合疾病模型和随机药代动力学模型,可为研究药物依从性对如艾滋病等慢性疾病长期治疗的影响提供潜在支持。

相似文献

1
Statistical analysis of one-compartment pharmacokinetic models with drug adherence.具有药物依从性的一室药代动力学模型的统计分析
J Pharmacokinet Pharmacodyn. 2022 Apr;49(2):209-225. doi: 10.1007/s10928-021-09794-5. Epub 2021 Oct 27.
2
Statistical Analysis of Two-Compartment Pharmacokinetic Models with Drug Non-adherence.具有药物不依从性的两室药代动力学模型的统计分析。
Bull Math Biol. 2023 Jun 9;85(7):65. doi: 10.1007/s11538-023-01173-0.
3
Designing Drug Regimens that Mitigate Nonadherence.设计减轻不依从性的药物治疗方案。
Bull Math Biol. 2021 Dec 20;84(1):20. doi: 10.1007/s11538-021-00976-3.
4
Comparison of Population Pharmacokinetics Based on Steady-State Assumption Versus Electronically Monitored Adherence to Lopinavir, Atazanavir, Efavirenz, and Etravirine: A Retrospective Study.基于稳态假设的群体药代动力学与洛匹那韦、阿扎那韦、依非韦伦和依曲韦林电子监测依从性的比较:一项回顾性研究。
Ther Drug Monit. 2016 Aug;38(4):506-15. doi: 10.1097/FTD.0000000000000297.
5
Pharmacokinetic variability and therapeutic drug monitoring actions at steady state.
Pharm Res. 2000 May;17(5):589-92. doi: 10.1023/a:1007573001055.
6
How drug onset rate and duration of action affect drug forgiveness.药物起效速率和作用持续时间如何影响药物宽恕。
J Pharmacokinet Pharmacodyn. 2024 Jun;51(3):213-226. doi: 10.1007/s10928-023-09897-1. Epub 2024 Jan 10.
7
Simulation for population analysis of Michaelis-Menten elimination kinetics.米氏消除动力学群体分析的模拟
J Pharmacokinet Biopharm. 1995 Apr;23(2):205-16. doi: 10.1007/BF02354272.
8
Pharmacometrics: modelling and simulation tools to improve decision making in clinical drug development.药物计量学:用于改善临床药物开发决策的建模与模拟工具。
Eur J Drug Metab Pharmacokinet. 2000 Jan-Mar;25(1):49-58. doi: 10.1007/BF03190058.
9
Analytical Solution and Exposure Analysis of a Pharmacokinetic Model with Simultaneous Elimination Pathways and Endogenous Production: The Case of Multiple Dosing Administration.具有同时消除途径和内源性产生的药代动力学模型的分析解和暴露分析:多次给药的情况。
Bull Math Biol. 2019 Sep;81(9):3436-3459. doi: 10.1007/s11538-019-00651-8. Epub 2019 Aug 16.
10
Variability and singularity arising from poor compliance in a pharmacokinetic model I: the multi-IV case.源于药代动力学模型中较差依从性的可变性和奇点 I:多 IV 情况。
J Pharmacokinet Pharmacodyn. 2013 Feb;40(1):15-39. doi: 10.1007/s10928-012-9284-y. Epub 2012 Dec 30.

引用本文的文献

1
Artificial Intelligence to Close the Gap between Pharmacokinetic/Pharmacodynamic Targets and Clinical Outcomes in Critically Ill Patients: A Narrative Review on Beta Lactams.人工智能缩小重症患者药代动力学/药效学靶点与临床结局之间的差距:关于β-内酰胺类药物的叙述性综述
Antibiotics (Basel). 2024 Sep 6;13(9):853. doi: 10.3390/antibiotics13090853.